News

Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions of S2 Genomics and ...
CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.